Veru to report fiscal 2020 fourth-quarter, full-year financial results, host conference call on december 9th

Miami, nov. 23, 2020 (globe newswire) -- veru inc. (nasdaq: veru), an oncology and urology biopharmaceutical company with a focus on developing novel medicines for the management of prostate cancer, today announced that it will report financial results for its fiscal 2020 fourth quarter and full year ended september 30, 2020, on wednesday, december 9, 2020, before the market opens.   veru's management will host a conference call that same day at 8 a.m. et to review the company's performance and to answer questions. the call will also be accessible via webcast.
VERU Ratings Summary
VERU Quant Ranking